Resources Blog Recombinant Antibodies

Recombinant Antibodies

Biointron 2024-01-20 Read time: 2 mins
Recombinant-antibody.jpg
Image credit: DOI: 10.3389/fvets.2018.00175

Recombinant antibodies are synthetic proteins created by combining different parts of antibody molecules from different sources. These molecules can be customized to target specific antigens, making them a powerful tool in the fields of medicine and biotechnology. 

Traditional antibodies are made by the body's immune system to identify and neutralize foreign substances like bacteria or viruses. Recombinant antibodies, on the other hand, are designed in a laboratory to target specific molecules, such as those found on the surface of cancer cells. 

One of the main advantages of recombinant antibodies is their ability to be produced on a large scale, making them useful in the development of diagnostic tools and therapeutic drugs. At Biointron, we specialize in creating high-quality recombinant antibodies through our fast and efficient platform. 

Our team of experts can create recombinant antibodies from scratch, starting with gene synthesis all the way to protein purification. Our service is designed to accelerate your research and drug discovery projects with high-quality recombinant antibodies at an economical price. 

To learn more about how our recombinant antibody service can benefit your research, visit our website at https://www.biointron.com/recombinant-antibody-production.html. 

Subscribe to our Blog

Recent Blog

Computational antibody methods schematic. DOI: 10.1093/bib/bbz095The development of therapeutic antibodies has been significantly enhanced by advancements in computational methods and artificial intelligence (AI). These technologies have streamlined the antibody discovery process, improving the abil

May 27, 2024
Blog

Welcometo Antibody Basics by Biointron,Part 8. In this episode, we’ll talk about therapeutics targeting cancer.What is cancer immunotherapy?Cancer immunotherapy leverages the body's immune system to fight cancer more selectively and effectively than traditional methods such as chemotherapy

May 24, 2024
Blog

The generation of an immune response to a vaccine. DOI: 10.1038/s41577-020-00479-7Vaccination is one of the most effective tools in preventing infectious diseases. At its core, the success of a vaccine hinges on its ability to induce a robust and lasting antibody response against a specific pathogen

May 22, 2024
Blog

Innovation orientation and goals for transforming CAR-T cell engineering. DOI: 10.1186/s13045-020-00910-5Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary cancer treatment in which engineered CARs redirect lymphocytes, typically T cells, to recognize and destroy cells expressing a sp

May 20, 2024
Blog

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.